Cymat Technologies Ltd. Can’t Be More Safe. Trades Significantly Higher

 Cymat Technologies Ltd. Can't Be More Safe. Trades Significantly Higher

The stock of Cymat Technologies Ltd. (CVE:CYM) is a huge mover today! About 34,000 shares traded hands. Cymat Technologies Ltd. (CVE:CYM) has risen 6.00% since October 17, 2016 and is uptrending. It has outperformed by 1.31% the S&P500.
The move comes after 7 months positive chart setup for the $5.29 million company. It was reported on Nov, 16 by Barchart.com. We have $0.78 PT which if reached, will make CVE:CYM worth $8.62M more.

More notable recent Cymat Technologies Ltd. (CVE:CYM) news were published by: Stockhouse.com which released: “IIROC Trade Resumption – Cymat Technologies Ltd.” on June 11, 2012, also Businesswire.com with their article: “Global Metal Matrix Composites Market Growth of 5.9% CAGR by 2020 – Analysis …” published on May 31, 2016, Marketwired.com published: “Gideon Capital Corp. Announces Closing of Amalgamation With Bathurst Resources …” on January 06, 2014. More interesting news about Cymat Technologies Ltd. (CVE:CYM) were released by: Prnewswire.com and their article: “The Aluminium Market Analysis, Financials and Forecasting 2011-2016” published on October 17, 2011 as well as Theglobeandmail.com‘s news article titled: “Globe Investor” with publication date: May 20, 2009.

Cymat Technologies Ltd. is a manufacturing company, which holds licenses and related patents to make, use and sell stabilized aluminum foam . The company has a market cap of $5.29 million. SAF is a metallic foam, which is produced using a process in which gas is bubbled into molten-alloyed aluminum containing a dispersion of fine ceramic particles to create a foam that is then cast into lightweight panels and shapes. It currently has negative earnings. The Company’s business lines include Architecture, Blast Mitigation and Energy Absorption, and Automotive.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment